Your browser version may not work well with NCBI's Web applications. More information here...
1: Pharmacol Biochem Behav. 1996 May;54(1):261-7.Click here to read Links

Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety.

Korte SM, Korte-Bouws GA, Koob GF, De Kloet ER, Bohus B.

Department of Animal Physiology, University of Groningen, Haren, The Netherlands.

The behavioral effects of intracerebroventricular (i.c.v.) administration of a specific mineralocorticoid receptor (MR) antagonist [RU28318 (10-50 ng/2 microliters)], a glucocorticoid receptor (GR) antagonist [RU38486 (1-50 ng/2 microliters)], or both antagonists (50 ng/2 microliters), were studied in two different animal models of fear and anxiety in rats. In the defensive burying paradigm simultaneous blockade of MR and GR increased immobility behavior, whereas a small decrease in defensive burying was seen. In the fear-potentiated startle test concurrent MR and GR blockade led to an increase in fear-potentiated startle at the highest loudness level (105 dB). In both tests the antagonists were not effective when given separately. The findings are discussed in terms of the involvement of GR and MR in neural mechanisms of fear and anxiety.

PMID: 8728567 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Spironolactone (Aldactone® )

    Spironolactone is used to treat certain patients with hyperaldosteronism (the body produces too much aldosterone, a naturally occurring hormone); low potassium levels; and in patients with edema (fluid retention) caused ...

  • Mifepristone (Mifeprex® )

    Mifepristone is used alone or in combination with misoprostol (Cytotec) to end an early pregnancy. Early pregnancy means it has been 49 days or less since your last menstrual period began. Mifepristone is in a class of m...

  • Source: AHFS Consumer Medication Information